Prediction of Therapeutic Response and Prognosis in Ovarian Cancer Patients With Plasma Circulating Biomarkers

Prediction of Therapeutic Response and Prognosis in Ovarian Cancer Patients With Plasma Circulating Biomarkers

ABSTRACT Background To assess whether changes in TP53 mutations and copy number alterations (CNA) in plasma circulating tumor DNA (ctDNA) can predict treatment response and prognosis in platinum‐resistant recurrent ovarian cancer (PROC) patients. Methods Fifty‐seven PROC patients were recruited. For...

Full description

Saved in:
Bibliographic Details
Main Authors: Haixia Cheng, Guangwen Yuan, Leilei Liang, Tiantian Wang, Jiarun Zhu, Hongying Yang, Zhendiao Zhou, Pei Wang, Qianqian Song, Yuchen Jiao, Mei Liu, Lingying Wu
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Cancer Innovation
Subjects:
circulating tumor DNA
copy number alterations
ovarian cancer
TP53 mutations
Online Access:https://doi.org/10.1002/cai2.70014
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cai2.70014

Similar Items